Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-c... Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0769 | -15.7905544148 | 0.487 | 0.529 | 0.36 | 65208 | 0.41951966 | CS |
4 | -0.2949 | -41.829787234 | 0.705 | 0.787899 | 0.36 | 78822 | 0.55095025 | CS |
12 | -0.4699 | -53.3977272727 | 0.88 | 0.94 | 0.36 | 82083 | 0.70812558 | CS |
26 | -1.1499 | -73.7115384615 | 1.56 | 1.56 | 0.36 | 89922 | 0.86781876 | CS |
52 | -4.8799 | -92.247637051 | 5.29 | 5.65 | 0.36 | 78836 | 1.33508437 | CS |
156 | -15.9399 | -97.4917431193 | 16.35 | 19.35 | 0.36 | 243337 | 8.16734796 | CS |
260 | -61.6899 | -99.3396135266 | 62.1 | 158.1 | 0.36 | 439355 | 42.46344181 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관